The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 17, 2023

Filed:

Jul. 29, 2019
Applicant:

Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;

Inventors:

Michael Bohm, Saarlan, DE;

Felix Mahfoud, Saarlan, DE;

Sandeep Brar, Dublin, CA (US);

Douglas Hettrick, Andover, MN (US);

Martin Fahy, Brooklyn, NY (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/02 (2006.01); A61B 17/32 (2006.01); A61N 1/40 (2006.01); A61B 18/00 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1492 (2013.01); A61B 17/320068 (2013.01); A61B 18/02 (2013.01); A61N 1/403 (2013.01); A61B 2017/00022 (2013.01); A61B 2017/00778 (2013.01); A61B 2017/320069 (2017.08); A61B 2018/0022 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/0212 (2013.01);
Abstract

Methods for treating hypertension and associated systems and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods for therapeutic renal neuromodulation that partially inhibit sympathetic neural activity in renal nerves proximate a renal blood vessel of a human patient having a 24-hour heart rate at or above a median heart rate for a population of hypertensive patients. This reduction in sympathetic neural activity is expected to therapeutically treat one or more conditions associated with hypertension of the patient. Renal sympathetic nerve activity can be modulated, for example, using an intravascularly positioned catheter carrying a neuromodulation assembly, e.g., a neuromodulation assembly configured to use electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the renal nerves.


Find Patent Forward Citations

Loading…